GRALGRAIL, Inc.

GRAL Stock Price, Valuation & Chart | GRAIL, Inc.

Compare

$117.81-17.65 (-13.03%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research

Overview Financials Dividends Ratios

GRAL Historical price chart

GRAL Key Stats

Market Capitalization5.26B

PE Ratio-12.08

EPS-9.75

Trading Volume1.30M

Today's High/Low137.47/117.06

Dividend Yield0.00

52 Week High/Low166.48/41.5

Shares Outstanding44.67M

GRAL Financial Statement

GRAL Analyst ratings

GRAL Analysis & performance metrics

GRAL Company profile

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic…

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease…

GRAL Management team

Name

Position

Alison Highlander

Senior Vice President of Human Resources & Head of People Team

Trish Rowland

Vice President of Corporate Communications

Aaron FreidinCFO

Chief Financial Officer

Paul Ciccolella

Senior Vice President of Research, Development & Operations

Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng

President of International Business & BioPharma

Satnam Alag Ph.D.

Senior Vice President of Software Engineering & Chief Security Officer

Abram Barth J.D., M.P.H.

General Counsel

Rodger Currie J.D.

Senior Vice President of Government Affairs

Name

Position

Alison Highlander

Senior Vice President of Human Resources & Head of People Team

Trish Rowland

Vice President of Corporate Communications

Aaron FreidinCFO

Chief Financial Officer

Paul Ciccolella

Senior Vice President of Research, Development & Operations

Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng

President of International Business & BioPharma

Satnam Alag Ph.D.

Senior Vice President of Software Engineering & Chief Security Officer

Abram Barth J.D., M.P.H.

General Counsel

Rodger Currie J.D.

Senior Vice President of Government Affairs

Management Team

Alison Highlander

Senior Vice President of Human Resources & Head of People Team

Trish Rowland

Vice President of Corporate Communications

Aaron FreidinCFO

Chief Financial Officer

Paul Ciccolella

Senior Vice President of Research, Development & Operations

Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng

President of International Business & BioPharma

Satnam Alag Ph.D.

Senior Vice President of Software Engineering & Chief Security Officer

Abram Barth J.D., M.P.H.

General Counsel

Rodger Currie J.D.

Senior Vice President of Government Affairs

Management

Alison Highlander

Senior Vice President of Human Resources & Head of People Team

Trish Rowland

Vice President of Corporate Communications

Aaron FreidinCFO

Chief Financial Officer

Paul Ciccolella

Senior Vice President of Research, Development & Operations

Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng

President of International Business & BioPharma

Satnam Alag Ph.D.

Senior Vice President of Software Engineering & Chief Security Officer

Abram Barth J.D., M.P.H.

General Counsel

Rodger Currie J.D.

Senior Vice President of Government Affairs

Total 8 executives

GRAL Frequently asked questions

What is GRAIL, Inc. (GRAL) Stock Price?

Current stock price of GRAIL, Inc. (GRAL) stock is $117.81. The stock price is -13.03% lower in the session. The intraday range can be seen from this page. Volume of GRAIL, Inc. (GRAL) stock is 1.30M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the GRAIL, Inc. (GRAL) stock price going up or down today?

The stock price of GRAIL, Inc. (GRAL) can change with earnings, company news, and overall market sentiment. GRAIL, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the GRAIL, Inc. stock expensive at its current price?

Whether GRAIL, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GRAL on this page is -12.08. EPS on this page is -9.75. Compare those figures with peers and growth expectations before deciding if the current GRAIL, Inc. price is justified.

How has the stock price of GRAIL, Inc. (GRAL) performed historically?

Historical performance for GRAIL, Inc. (GRAL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GRAL reacted to past earnings and market events.

Should I buy GRAIL, Inc. (GRAL) stock, at this price?

Buying GRAIL, Inc. (GRAL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.